- Seegene is launching the Global Million Clinical Study at the scale of one million test cases to shape disease-specific testing standards.
- The study is designed to evaluate the clinical utility of syndromic PCR testing approaches and build real-world scientific evidence to support better-informed clinical decision-making.
- The company is recognized as one of TIME's "The World's Most Impactful Companies of 2026," highlighting its work to address high-priority global challenges as part of its core business, as well as its global economic reach and positive impact on the world.
SEOUL, South Korea, July 8, 2026 /PRNewswire/ -- Seegene today announced the launch of the Global Million Clinical Study (GMCS), aiming to evaluate the clinical utility and potential impact of comprehensive syndromic PCR testing approaches using real-world data.
This project is scheduled to begin in South Korea and at healthcare institutions across the world to accumulate large-scale global testing data and assess the clinical value of disease-specific testing approaches for major infectious diseases. The goal is to build the scientific basis for new global testing standards and support a more comprehensive and accurate diagnostic environment, in which everyone, regardless of country or region, can access the best testing currently available.
For this project, Seegene provides STAgora™, a real-time testing data analytics platform. The platform is intended to support statistical analysis of pathogen prevalence and infection trends across disease types and geographic regions.
- GMCS to Generate Real Testing Data While Maintaining Existing Clinical Practice
GMCS aims to go beyond conventional targeted testing and assess the clinical value of comprehensive PCR testing that enables the multiple detection of major causative pathogens in a single test. The study will analyze real-world testing data that has been difficult to fully capture through conventional testing alone, including previously undetected pathogens, co-infections, genotypes, and regional and seasonal epidemiological patterns.
- Evaluating Disease-Specific Diagnostic Strategies
The study will initially focus on major infectious disease types, including reproductive tract infections, respiratory tract infections and gastrointestinal tract infections. By doing so, the study aims to bring additional testing insights beyond those provided by existing testing methods and assess how this information may support clinical decision-making.
- Creating Evidence-Based Insights for New Testing Standards
State-of-the-art PCR diagnostic technologies can provide a consistent level of diagnostic capability. However, actual testing practices may depend on each country's healthcare environment. Even for the same disease, target pathogens, recommended testing protocols and reimbursement policies differ according to national clinical guidelines and healthcare systems. This means that patients with the same disease may have access to different levels and scopes of diagnostic testing, shaped by the testing strategies and healthcare systems of their respective countries.
Accordingly, Seegene aims to build an important scientific evidence basis to drive new global testing standards aligned with real-world clinical needs.
"GMCS goes beyond simply accumulating real-world testing data," said Dr. Jong-Yoon Chun, CEO & Founder of Seegene. "It is the industry's first global clinical study of this scale, designed to compile scientific evidence to help open a new paradigm in diagnostics."
"Innovation at Seegene does not end with developing advanced technologies," Dr. Chun added. "Our goal is to translate advanced technology into new testing strategies in the global healthcare environment. By continuously accumulating scientific evidence, we hope to bring better diagnostic options for patients."
Dr. Chun also emphasized the company's long-term vision of expanding access to high-quality diagnostics worldwide.
"Everyone deserves access to high-quality diagnostic testing, regardless of where they live," he said. "More comprehensive and accurate diagnostics can support earlier and more informed clinical decision-making and help reduce the spread of infectious diseases. Through real-world clinical evidence generated by GMCS, we aim to support diagnostic strategies that allow patients worldwide to benefit from a high level of diagnostic excellence."
Notice
GMCS is an evidence-generation initiative and does not constitute medical advice, diagnostic guidance or a product-specific performance claim.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Seegene Launches Industry's First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
IRVINE, Calif., July 9, 2026 /PRNewswire/ -- For creators, makers, studios, and small businesses, color has remained one of the biggest barriers in digital fabrication. Multi-color FDM is limited in detail and often creates waste towers, while resin 3D printing delivers fine detail but requires manual painting for color. Full-color 3D printing has traditionally been expensive and out of reach, with UV printing and texture creation still locked in separate workflows.
The HeyGears G1X is designed to change that. As the world's first desktop full-color 3D & UV printer, G1X combines Full-Color 3D, 3D Texture, and 2D UV printing in one desktop-scale platform. From paint-free full-color models and tactile relief effects to high-resolution surface customization across hundreds of materials, G1X gives creators a faster, more flexible way to turn digital ideas into finished physical products.
Secure your VIP early bird slot today for just $50 and receive a free 300ml bottle of White UV Ink (valued at $39) with your printer!
One Machine. Three Worlds of Creation.
The HeyGears G1X combines Full-Color 3D, 3D Texture, and 2D UV printing in one desktop system.
3D Printing Mode (Prints Full-Color 3D Models & 2.9D Deep Relief)
In 3D Mode, the G1X builds three-dimensional models layer by layer using a dedicated ink set: CMYK + Double White + Water-Soluble Support + Transparent (CMYKST+W*2). This mode produces:
- Full-Color 3D Models: Seamless, paint-free models with interior and exterior color.
- Deep Relief (2.9D): A specialized application of full-color 3D printing for deep three-dimensional relief, extending your prints up to 150 mm for enhanced expression.
UV Printing Mode (2D Printing & 3D Texture Printing)
In UV mode, the G1X 8-channel ink system and up to 1440 × 2400 DPI resolution support vivid color, fine detail, raised textures, and surface customization across 400+ compatible materials. It functions as a high-speed flatbed printer capable of producing two types of creations:
- 2D Printing: Direct high-resolution printing on 400+ compatible materials (metal, acrylic, wood, leather, ceramics).
- 3D Textures: Supports up to 10 mm of 3D texture height, though a maximum of 5 mm is recommended for superior print quality and stability, allowing you to reproduce realistic surfaces like leather, wood carving, brushstrokes, and braille.
Lower Running Costs, Built for Long-Term Use
The G1X is designed to keep everyday production more cost-efficient, not just more capable. Its affordable ink system helps reduce consumable costs for frequent printing, while the Epson I3200-U1HD (used in G1X) industrial-grade printhead delivers stable performance with reduced clogging risk and a longer service life. With fewer interruptions, lower maintenance needs, and less frequent printhead replacements, the G1X helps creators, studios, and small businesses achieve reliable output while keeping long-term operating costs under control.
Industrial-Grade Print Quality, Speed, and Color Fidelity
G1X is designed to bring industrial-grade print performance into a desktop-scale system, combining faster UV printing, precise color reproduction, and stable long-term output.
- Epson I3200 industrial-grade printhead: Supports ultra-high-frequency jetting for faster printing, stable ink ejection, and reduced clogging risk.
- Up to 3X faster UV printing: Helps creators, studios, and small businesses improve productivity for custom projects and small-batch production.
- Advanced Raster Image Processor (RIP) algorithms: Enable 10M+ colors, smoother gradients, and more accurate visual output across different printing modes.
Note: The 3X UV printing speed boost is based on internal testing compared with desktop UV printers equipped with a single F1080 (XP600) printhead.
From Idea to Print with AI and Auto Calibration
G1X combines AI-powered creation tools with intelligent hardware alignment, making the workflow from idea to final print faster and easier.
- AI-powered modeling: With HeyVerse AI and Blueprint Studio, users can generate high-fidelity models from text or images, or convert 2D visuals into 3D Texture outputs through a simplified workflow.
- Auto calibration in seconds: Line-scan imaging identifies an object's position, shape, and edges, enabling accurate design alignment and smart layout in Blueprint Studio for more efficient, consistent batch production.
- Full-stack creation workflow: With HeyVerse, Blueprint Studio, 500+ curated assets, and text/image-to-3D generation, users can turn ideas into printable models in minutes—even without 3D modeling experience.
Early Access and Deposit Reservation
The HeyGears G1X is launching soon on Kickstarter. Join our waitlist now to secure early bird pricing.
Secure your VIP early bird slot today for just $50 and receive a free 300ml bottle of White UV Ink (valued at $39) with your printer!
About HeyGears
HeyGears specializes in 3D printing and digital manufacturing, delivering precision solutions across dental, rehabilitation, and consumer applications. From medical personalization to consumer innovation, we help restore, reshape, and reimagine what's possible—making advanced manufacturing more accessible. To learn more about HeyGears products, visit store.heygears.com or contact contact@heygears.com.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
HeyGears Unveils G1X, the World's First Desktop Full-Color 3D & UV Printer
